Greater fuel efficiency is potentially preferable to reducing NOx emissions for aviation’s climate impacts

Aviation emissions of nitrogen oxides (NOx) alter the composition of the atmosphere, perturbing the greenhouse gases ozone and methane, resulting in positive and negative radiative forcing effects, respectively. In 1981, the International Civil Aviation Organization adopted a first certification standard for the regulation of aircraft engine NOx emissions with subsequent increases in stringency in 1992, 1998, 2004 and 2010 to offset the growth of the environmental impact of air transport, the main motivation being to improve local air quality with the assumed co-benefit of reducing NOx emissions at altitude and therefore their climate impacts. Increased stringency is an ongoing topic of discussion and more stringent standards are usually associated with their beneficial environmental impact. Here we show that this is not necessarily the right direction with respect to reducing the climate impacts of aviation (as opposed to local air quality impacts) because of the tradeoff effects between reducing NOx emissions and increased fuel usage, along with a revised understanding of the radiative forcing effects of methane. Moreover, the predicted lower surface air pollution levels in the future will be beneficial for reducing the climate impact of aviation NOx emissions. Thus, further efforts leading to greater fuel efficiency, and therefore lower CO2 emissions, may be preferable to reducing NOx emissions in terms of aviation’s climate impacts

The position of mefloquine as a 21st century malaria chemoprophylaxis

BACKGROUND: Malaria chemoprophylaxis prevents the occurrence of the symptoms of malaria. Travellers to high-risk Plasmodium falciparum endemic areas need an effective chemoprophylaxis. METHODS: A literature search to update the status of mefloquine as a malaria chemoprophylaxis. RESULTS: Except for clearly defined regions with multi-drug resistance, mefloquine is effective against the blood stages of all human malaria species, including the recently recognized fifth species, Plasmodium knowlesi. New data were found in the literature on the tolerarability of mefloquine and the use of this medication by groups at high risk of malaria. DISCUSSION: Use of mefloquine for pregnant women in the second and third trimester is sanctioned by the WHO and some authorities (CDC) allow the use of mefloquine even in the first trimester. Inadvertent pregnancy while using mefloquine is not considered grounds for pregnancy termination. Mefloquine chemoprophylaxis is allowed during breast-feeding. Studies show that mefloquine is a good option for other high-risk groups, such as long-term travellers, VFR travellers and families with small children. Despite a negative media perception, large pharmaco-epidemiological studies have shown that serious adverse events are rare. A recent US evaluation of serious events (hospitalization data) found no association between mefloquine prescriptions and serious adverse events across a wide range of outcomes including mental disorders and diseases of the nervous system. As part of an in-depth analysis of mefloquine tolerability, a potential trend for increased propensity for neuropsychiatric adverse events in women was identified in a number of published clinical studies. This trend is corroborated by several cohort studies that identified female sex and low body weight as risk factors. CONCLUSION: The choice of anti-malarial drug should be an evidence-based decision that considers the profile of the individual traveller and the risk of malaria. Mefloquine is an important, first-line anti-malarial drug but it is crucial for prescribers to screen medical histories and inform mefloquine users of potential adverse events. Careful prescribing and observance of contraindications are essential. For some indications, there is currently no replacement for mefloquine available or in the pipeline

More rapid polar ozone depletion through the reaction of HOCI with HCI on polar stratospheric clouds

THE direct reaction of HOC1 with HC1, known to occur in liquid water1 and on glass surfaces2, has now been measured on surfaces similar to polar stratospheric clouds3,4 and is shown here to play a critical part in polar ozone loss. Two keys to understanding the chemistry of the Antarctic ozone hole5-7 are, one, the recognition that reactions on polar stratospheric clouds transform HC1 into more reactive species denoted by ClOx(refs 812) and, two, the discovery of the ClO-dimer (C12O2) mechanism that rapidly catalyses destruction of O3(refs 1315). Observations of high levels of OClO and ClO in the springtime Antarctic stratosphere1619 confirm that most of the available chlorine is in the form of ClOx (refs 20, 21). But current photochemical models22,23 have difficulty converting HC1 to ClOx rapidly enough in early spring to account fully for the observations5-7,20,21. Here I show, using a chemical model, that the direct reaction of HOC1 with HC1 provides the missing mechanism. As alternative sources of nitrogen-containing oxidants, such as N2O5 and ClONO2, have been converted in the late autumn to inactive HNO3 by known reactions on the sulphate-layer aerosols24-27, the reaction of HOC1 with HC1 on polar stratospheric clouds becomes the most important pathway for releasing that stratospheric chlorine which goes into polar night as HC1. © 1992 Nature Publishing Group

A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

Meeting abstrac

Influence of anthropogenic emissions on tropospheric ozone and its precursors over the Indian tropical region during a monsoon

An emission inventory of ozone precursors developed for the year 1991 and 2001 is used in a Chemistry-Transport Model (MOZART) to examine the tropospheric changes in ozone and its precursors that have occurred during the 1990s in the geographical region of India in response to enhanced human activities. The maximum variation in ozone concentration near the surface is found to be around 5-10 ppbv. It reaches 5-7 in the lower part of the free troposphere and 3-5 in the upper troposphere. The maximum decadal increase in CO and NOx is about 50-70 ppbv (10-18) and 0.5-1.5 ppbv (20-50), respectively in the boundary layer. However, in most of the troposphere, the relative magnitude reduces with height and becomes less then 5 above 10 km. The variation in some of the volatile organic compounds is found to be significant

Segregation of atmospheric oxidants in turbulent urban environments

202212 bckwVersion of RecordPublishe

Twenty-five years of lower tropospheric ozone observations in tropical East Asia : the Influence of emissions and weather patterns

202209 bcvcAccepted ManuscriptRGCOthersPolyU HKPublishe

Evaluation of the CAMS global atmospheric trace gas reanalysis 2003-2016 using aircraft campaign observations

202008 bcrcVersion of RecordPublishe